Ledger.Open graph →
SEC Form D · filed May 30, 2024

Volastra Therapeutics, Inc

Offering
$15.0M
Sold
$15.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Samuel Z. Bakhoum · New York, NYDirectorSandra Z. Peterson · New York, NYDirectorStefan Z. Vitorovic · New York, NYDirectorCharles Hugh-Jones · New York, NYExec · DirectorArjun Z. Balar · New York, NYDirectorDavid Z. Nicholson · New York, NYDirectorDavid Dwaihy · Detroit, MIDirectorTodd Kropp · Detroit, MIExec · DirectorPatrick P. Luo · San Francisco, CADirectorMichael Lasinski · Detroit, MIDirectorEileen Z. Mcguire · New York, NYDirectorRachel Z. Schwartz · New York, NYExecScott Drutman · New York, NYExecRez Z. Halze · New York, NYDirectorSai Fai Yip · Singapore, U0DirectorJohn F. Burke · ARLINGTON, VAExec · DirectorMeg Reynolds · Park City, UTDirectorHeather Solberg · Ames, IADirectorArjun Z. Balar · New York, NYDirectorEileen Z. Mcguire · New York, NYDirectorRachel Z. Schwartz · New York, NYExecScott Drutman · New York, NYExecDavid Z. Nicholson · New York, NYDirectorRez Z. Halze · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗